NRX Pharmaceuticals
NRXP
NRXP
22 hedge funds and large institutions have $4.6M invested in NRX Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
12% less funds holding
Funds holding: 25 → 22 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
22
Holding in Top 10
–
Calls
$310K
Puts
$6K
Top Buyers
| 1 | +$2.04M | |
| 2 | +$305K | |
| 3 | +$183K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$124K |
| 5 |
Two Sigma Investments
New York
|
+$61.8K |
Top Sellers
| 1 | -$181K | |
| 2 | -$60.8K | |
| 3 | -$55.7K | |
| 4 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$45.6K |
| 5 |
SCA
Sassicaia Capital Advisers
Jericho,
New York
|
-$33K |
